Top Stories http://www.benzinga.com/views/taxonomy/term/138079 en Bank Of America Raises AMD Target On Market Share Optimism http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11928499/bank-of-america-raises-amd-target-on-market-share-optim <p><strong>Advanced Micro Devices, Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) is gaining market share from <strong>Intel Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>), and one analyst says the market is too worried about AMD&rsquo;s graphics card business.</p> <h3>The Analyst</h3> <p>Bank of America analyst Vivek Arya reiterated his Buy rating for AMD and raised his price target from $17 to $20.</p> <h3>The Thesis</h3> <p>Slumping cryptocurrency mining demand for GPUs will be a headwind for AMD&rsquo;s sales, but Arya said AMD bears may be putting too much emphasis on crypto mining. He said AMD&rsquo;s Ryzen and EPYC products have tremendous pricing and gross margin upside, and Bank of America projects AMD&rsquo;s share of combined PC and server sales will ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11928499/bank-of-america-raises-amd-target-on-market-share-optim alt=Bank Of America Raises AMD Target On Market Share Optimism>Full story available on Benzinga.com</a></p> AMD Analyst Color Bank of America Cryptocurrency cryptocurrency mining EPYC INTC NVDA Ryzen Vivek Arya Price Target Reiteration Top Stories Markets Analyst Ratings INTC US4581401001 NVDA US67066G1040 AMD US0079031078 Analyst Color Cryptocurrency Price Target Reiteration Top Stories Markets Analyst Ratings Benzinga Mon, 25 Jun 2018 15:00:43 +0000 Wayne Duggan 11928499 at www.benzinga.com Merrimack Plummets 30% After Pancreatic Cancer Drug Doesn't Meet Endpoints http://www.benzinga.com/news/18/06/11928383/merrimack-plummets-30-after-pancreatic-cancer-drug-doesnt-meet-endpoints <p><strong>Merrimack Pharmaceuticals Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mack#NASDAQ">MACK</a>) plunged more than 30&nbsp;percent Monday after management <a href="https://www.benzinga.com/pressreleases/18/06/r11926692/merrimack-announces-top-line-results-from-randomized-phase-2-trial-of-">discontinued </a>the development of MM-141.</p> <p>The drug&rsquo;s Phase 2 trial for MM-141 in front-line metastatic pancreatic cancer did not meet primary or secondary endpoints.</p> <h3><strong>Why It&rsquo;s Important</strong></h3> <p>This is the second time in 18 months that Merrimack has <a href="https://www.benzinga.com/news/16/12/8830012/merrimack-stops-phase-2-study-of-breast-cancer-drug-shares-lose-20">killed </a>a Phase 2 candidate. Its stock never recovered from the discontinuation of MM-302, which catalyzed an 80-percent drop.</p> <p>With the ...</p><p><a href=http://www.benzinga.com/news/18/06/11928383/merrimack-plummets-30-after-pancreatic-cancer-drug-doesnt-meet-endpoints alt=Merrimack Plummets 30% After Pancreatic Cancer Drug Doesn&#039;t Meet Endpoints>Full story available on Benzinga.com</a></p> cancer MACK MM-141 MM-302 News Pancreatic Cancer Health Care Top Stories Movers Trading Ideas General MACK News Health Care Top Stories Movers Trading Ideas General Benzinga Mon, 25 Jun 2018 14:29:43 +0000 Elizabeth Balboa 11928383 at www.benzinga.com This Bond ETF Could Regain Its Angelic Status http://www.benzinga.com/trading-ideas/long-ideas/18/06/11925575/this-bond-etf-could-regain-its-angelic-status <p>Amid fears of rising interest rates in the U.S. and talk that default rates are climbing, some bond market experts expected a rough year for high-yield corporate debt.</p> <p>While there have been ample warnings regarding the health of the junk debt market, the <strong>iShares iBoxx $ High Yield Corporate Bond ETF</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hyg#NYSE">HYG</a>), the largest junk bond exchange trade fund, is up half a percent year-to-date. Conversely, the <strong>VanEck Vectors Fallen Angel High Yield Bond ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/angl#NYSE">ANGL</a>) is lower by 1.1 percent.</p> <h3>What Happened</h3> <p>Over much of its more than six years on the market, ANGL has outperformed traditional junk bond benchmarks with less volatility due in part to the fact ...</p><p><a href=http://www.benzinga.com/trading-ideas/long-ideas/18/06/11925575/this-bond-etf-could-regain-its-angelic-status alt=This Bond ETF Could Regain Its Angelic Status>Full story available on Benzinga.com</a></p> ANGL HYG Long Ideas VanEck Bonds Specialty ETFs Top Stories Markets Trading Ideas ETFs HYG US4642885135 ANGL Long Ideas Bonds Specialty ETFs Top Stories Markets Trading Ideas ETFs Benzinga Mon, 25 Jun 2018 14:13:48 +0000 ETF Professor 11925575 at www.benzinga.com Nomura Downgrades Intel Following CEO Departure http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11927926/nomura-downgrades-intel-following-ceo-departure <p><strong>Intel Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) abruptly and unexpectedly <a href="https://www.benzinga.com/news/18/06/11914432/intel-ceo-resigns-after-discovery-of-relationship-with-an-employee">saw CEO Brian Krzanich depart last week</a>, and one Wall Street analyst says there&#39;s now simply too much uncertainty surrounding Intel for investors to buy the stock.</p> <h3>The Analyst</h3> <p>Nomura analyst Romit Shah downgraded Intel&#39;s stock from Buy to Neutral and lowered his price target from $60 to $55.</p> <h3>The Thesis</h3> <p>Intel is losing server share to <strong>Advanced Micro Devices, Inc. </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>), Shah said in a note, and Intel&#39;s stock has simply run out of upside after gaining more than 50 percent in the past year.</p> <p>&ldquo;INTC&rsquo;s multiple started compressing before Mr. Krzanich&rsquo;s departure; lack of ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11927926/nomura-downgrades-intel-following-ceo-departure alt=Nomura Downgrades Intel Following CEO Departure>Full story available on Benzinga.com</a></p> AMD Analyst Color AVGO Brian Krzanich INTC Nomura Romit Shah Downgrades Price Target Top Stories Analyst Ratings Tech INTC US4581401001 AMD US0079031078 AVGO SG9999006241 Analyst Color Downgrades Price Target Top Stories Analyst Ratings Tech Benzinga Mon, 25 Jun 2018 13:55:49 +0000 Wayne Duggan 11927926 at www.benzinga.com Kraft Heinz Has Appetite For Campbell's, But JPMorgan Isn't Biting http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11927518/kraft-heinz-has-appetite-for-campbells-but-jpmorgan-isn <p><strong>Kraft Heinz Co </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/khc#NASDAQ">KHC</a>) has a soup craving.</p> <p>According to the <a href="https://nypost.com/2018/06/22/kraft-interested-in-buying-campbell-soup/">New York Post</a>, the company is interested in acquiring <strong>Campbell Soup Company</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpb#NYSE">CPB</a>), which announced a strategic review last month.</p> <h3>Why It&rsquo;s Important</h3> <p>The alleged attraction follows a nearly 20-percent Street retreat on Kraft Heinz. But by JPMorgan&rsquo;s assessment, a deal may not provide the desired relief.</p> <p>&ldquo;We would be surprised if KHC wanted CPB, a company that does not solve KHC&rsquo;s growth problem and is facing numerous internal challenges,&rdquo; analysts wrote Monday. &ldquo;So we do not expect a deal to take place. But in the ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11927518/kraft-heinz-has-appetite-for-campbells-but-jpmorgan-isn alt=Kraft Heinz Has Appetite For Campbell&#039;s, But JPMorgan Isn&#039;t Biting>Full story available on Benzinga.com</a></p> Analyst Color CPB GIS JPMorgan KHC New York Post News Snyder’s-Lance Rumors M&A Top Stories Analyst Ratings Media CPB US1344291091 GIS US3703341046 KHC News Analyst Color Rumors M&A Top Stories Analyst Ratings Media Benzinga Mon, 25 Jun 2018 13:12:09 +0000 Elizabeth Balboa 11927518 at www.benzinga.com The Market In 5 Minutes: Bonds, Treasury Yields, Russell Rebalance And More http://www.benzinga.com/news/18/06/11926917/the-market-in-5-minutes-bonds-treasury-yields-russell-rebalance-and-more <h3>IN THE NEWS</h3> <p>The Dow Jones Industrial Average closed 119 points higher on Friday at 24,580, putting an end to what threatened to be the index&rsquo;s longest losing streak in 40 years: <a href="https://www.benzinga.com/news/18/06/11923460/the-dow-averted-its-longest-losing-streak-in-40-years-does-it-matter">Link</a></p> <p>Index provider FTSE Russell finalized its annual index reconstitution Friday, making for brisk trading activity as well as some changes for some well-known exchange traded funds: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11918865/russell-1000-etfs-to-increase-in-health-care-tech-expos">Link</a></p> <p>The U.S. Treasury Department is drafting curbs that would block firms with at least 25 percent Chinese ownership from buying U.S. companies with &ldquo;industrially significant technology,&rdquo; a government official briefed on the matter said on Sunday: <a href="https://www.reuters.com/article/us-usa-trade-china-investment/u-s-plans-limits-on-chinese-investment-in-u-s-technology-firms-idUSKBN1JL03L?utm_campaign=MI5M%20Funnel&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=63999997&amp;_hsenc=p2ANqtz-_DQr9V28mIeyaYUPnGCxbYjd2DSbfu9ItL_Yx-VZ1slbyBjbw63OPH15VBGr5gBb3s7Y6Lzmnsf3ff_J49EhJg1qM_JA&amp;_hsmi=63999997">Link</a></p> <p><strong>General Electric Co.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ge#NYSE">GE</a>) is nearing ...</p><p><a href=http://www.benzinga.com/news/18/06/11926917/the-market-in-5-minutes-bonds-treasury-yields-russell-rebalance-and-more alt=The Market In 5 Minutes: Bonds, Treasury Yields, Russell Rebalance And More>Full story available on Benzinga.com</a></p> AMZN CIEN EL GE KR Market in 5 minutes MSFT News SPY Global Top Stories Pre-Market Outlook Markets SPY US78462F1030 AMZN US0231351067 CIEN US1717793095 MSFT US5949181045 EL US5184391044 GE US3696041033 KR US5010441013 News Global Top Stories Pre-Market Outlook Markets Benzinga Mon, 25 Jun 2018 13:00:21 +0000 Benzinga Newsdesk 11926917 at www.benzinga.com A Less Volatile Basket Of Global Stocks http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11925555/a-less-volatile-basket-of-global-stocks <p>The low volatility factor that&#39;s widely applied to U.S. equities has, thanks to exchange traded funds, made its way to international and global equity funds. A popular example is the <strong>iShares Edge MSCI Min Vol Global ETF</strong> (CBOE: ACWV).</p> <p>ACWV is the reduced volatility spin on the widely followed MSCI ACWI Index. The ETF, which is nearly seven years old, tracks the MSCI All Country World Minimum Volatility Index.</p> <h3>What Happened</h3> <p>Over the past three years, ACWV has outperformed the MSCI ACWI Index by 50 basis points while living up to its low volatility billing. ACWV&#39;s annualized volatility during that period was 370 basis points below that of MSCI ACWI Index.</p> <p>ACWV &ldquo;is a well-diversified global stock portfolio that takes a holistic approach toward reducing ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11925555/a-less-volatile-basket-of-global-stocks alt=A Less Volatile Basket Of Global Stocks>Full story available on Benzinga.com</a></p> ACWV Analyst Color Long Ideas Emerging Markets Specialty ETFs Top Stories Markets Analyst Ratings Trading Ideas ETFs ACWV Long Ideas Analyst Color Specialty ETFs Emerging Markets Top Stories Markets Analyst Ratings Trading Ideas ETFs Benzinga Mon, 25 Jun 2018 12:35:50 +0000 ETF Professor 11925555 at www.benzinga.com The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs http://www.benzinga.com/general/biotech/18/06/11916198/the-week-ahead-in-biotech-conferences-clinical-trials-and-ipos <p>Biotech stocks saw some upward momentum last week. The defensive nature of biotech stocks drove investors into the space amid a rise in risk aversion following the ongoing U.S.-China trade war. The week also saw a slew of initial public offerings.</p> <p>Looking ahead, here are the catalytic events in the unfolding week a biotech investor needs to be mindful about.</p> <h3>Conferences</h3> <ul> <li>6th Global Congress on Prostate Cancer &ndash; June 28-30 in Frankfurt, Germany.</li> <li>60th Annual Scientific Meeting of the American Headache Society (AHS) &ndash; June 28-July 1, in San Francisco, California.</li> </ul> <h3><strong>Drugs To Watch</strong></h3> <p><strong>Monday, June 25</strong></p> <p><strong>Achaogen Inc </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akao#NASDAQ">AKAO</a>) awaits FDA verdict on its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/18/05/11637500/why-achaogen-shares-are-getting-crushed-on-plazomicin-f">plazomicin</a> to treat complicated urinary tract infections (cUTI) and bloodstream infections (BSI).</p> <p><strong>Wednesday, June 27 </strong></p> <p>The FDA is set to rule on <strong> GW Pharmaceuticals PLC- ADR </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwph#NASDAQ">GWPH</a>)&#39;s epidiolex, which is being evaluated as an adjunctive treatment of seizures, with Lennox-Gastaut syndrome (LGS) and Dravet. FDA&#39;s Peripheral and Central Nervous System Drugs Advisory Committee, which met in April, unanimously recommended approval, of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11082287/why-gw-pharmas-epidiolex-results-could-shape-the-future">epidiolex</a>.</p> <p><strong>Saturday, June 30 </strong></p> <p>The FDA is due to announce its decision on <strong> Dermira Inc </strong> (NASDAQ: ...</p><p><a href=http://www.benzinga.com/general/biotech/18/06/11916198/the-week-ahead-in-biotech-conferences-clinical-trials-and-ipos alt=The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs>Full story available on Benzinga.com</a></p> AKAO ALDR ALKS APLS ARRY ASNS Biotech DERM DRRX GWPH IBB News PTIE Previews FDA IPOs Top Stories Trading Ideas ALKS IE00B56GVS15 ARRY US04269X1054 DRRX US2666051048 IBB US4642875565 PTIE US69562K1007 GWPH AKAO ALDR DERM APLS ASNS News Biotech Previews FDA IPOs Top Stories Trading Ideas Benzinga Sun, 24 Jun 2018 14:43:41 +0000 Shanthi Rexaline 11916198 at www.benzinga.com From 'Ellis Island' To Graffiti Canvas: The Story Of Ford's Newly Acquired Michigan Central Station http://www.benzinga.com/news/18/06/11920613/from-ellis-island-to-graffiti-canvas-the-story-of-fords-newly-acquired-michigan- <p>If buildings could blush, the Michigan Central Station would have turned red from embarrassment a decade ago.</p> <p>The 13-story, 625,382-square-foot building is one of the Detroit&#39;s most-photographed, from every angle and for every purpose, from wedding photos to drone fly-throughs.&nbsp;</p> <p>The Beaux Arts train depot&#39;s appeal can be chalked up to both its landmark architecture and the dystopian sense of decay it conveyed after the last train left the station in 1988.</p> <p>The sprawling structure &mdash; which was never fully used, even when the station was at its busiest &mdash; sat without windows until the end of 2015 and was open to frequent trespass by scrappers, graffiti artists, vandals, thrill-seekers and photographers for years until its longtime owner, the Moroun family, finally secured it properly.</p> <p>On Tuesday, the station was decked in blue as its new owner, <strong>Ford Motor Company </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>), announced it will be the centerpiece of the automaker&#39;s <a href="https://www.benzinga.com/news/18/06/11902613/ford-motor-buys-michigan-central-station-its-time-to-remake-this-into-a-place-of">next-generation mobility campus in the Corktown neighborhood</a>.</p> <p>Executive Chairman Bill Ford Jr. said the depot is reflective of Detroit&#39;s boom-and-bust history in many ways.</p> <p>&quot;It&#39;s time to remake the station into a place of possibility again,&quot; Ford said Tuesday.</p> <p><img alt="michigan_central_train_station_exterior_2010.jpg" src="https://www.benzinga.com/files/images/2018/June/22/michigan_central_train_station_exterior_2010.jpg" style="height:400px; width:600px" /></p> <p><em>The Michigan Central Train Station, as seen from Roosevelt Park in Detroit. Photo by <a href="https://commons.wikimedia.org/wiki/File:Michigan_Central_Train_Station_Exterior_2010.jpg">Albert Duce, 2010</a> (Wikimedia).</em></p> <h3>From Immigrant Landing Point To Movie Set</h3> <p>Michigan Central Station went into ...</p><p><a href=http://www.benzinga.com/news/18/06/11920613/from-ellis-island-to-graffiti-canvas-the-story-of-fords-newly-acquired-michigan- alt=From &#039;Ellis Island&#039; To Graffiti Canvas: The Story Of Ford&#039;s Newly Acquired Michigan Central Station>Full story available on Benzinga.com</a></p> Bill Ford Jr. Detroit F Michigan Central Station Education Top Stories General F US3453708600 Education Top Stories General Benzinga Sat, 23 Jun 2018 14:27:13 +0000 Dustin Blitchok 11920613 at www.benzinga.com Today In Cryptocurrency: Japan Money Laundering Crackdown, Market Flooded With ICOs http://www.benzinga.com/markets/cryptocurrency/18/06/11923161/today-in-cryptocurrency-japan-money-laundering-crackdown-marke <p>The cryptocurrency market finished yet another week on a low note Friday, with most major cryptocurrencies trading down more than 8 percent on the day. Here&rsquo;s a look at some of the headlines that were moving the cryptocurrency market today &mdash; and which currencies were on the move.</p> <h3>Headlines</h3> <p>The <a href="https://www.cnbc.com/2018/06/22/bitcoin-tumbles-after-japan-watchdog-orders-exchanges-to-review-business-practices.html">big news</a> that rocked the cryptocurrency markets on Friday was reports that Japan&rsquo;s financial regulator has begun cracking down on crypto exchanges for money laundering. Japan&rsquo;s largest crypto exchange, bitFlyer, even announced it was suspending the creation of new accounts while it improves its verification process. Regulators are cracking down around the world after one recent study by the University of Sidney ...</p><p><a href=http://www.benzinga.com/markets/cryptocurrency/18/06/11923161/today-in-cryptocurrency-japan-money-laundering-crackdown-marke alt=Today In Cryptocurrency: Japan Money Laundering Crackdown, Market Flooded With ICOs>Full story available on Benzinga.com</a></p> Bitcoin bitFlyer Cryptocurrency GBTC Japan Litecoin News today in cryptocurrency Top Stories After-Hours Center Markets GBTC News Cryptocurrency Top Stories After-Hours Center Markets Benzinga Sat, 23 Jun 2018 00:37:28 +0000 Wayne Duggan 11923161 at www.benzinga.com Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week http://www.benzinga.com/general/biotech/18/06/11923319/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee <p>This was a huge week for the marijuana industry: Canada became the second country in the world to legalize cannabis for recreational uses.</p> <p>&ldquo;October 17 was set as the first day for recreational sales. Some people in the industry wanted an earlier date, but at least companies can now make plans for a specific date,&rdquo; Debra Borchardt, CEO of Green Market Report told Benzinga.</p> <p>Other experts&nbsp;<a href="http://www.benzinga.com/government/18/06/11911059/canada-legalizes-recreational-marijuana-nationwide-beginning-oct-17-expert">highlighted the impact of Canada&rsquo;s move on the international realm</a>. Jeff Siegel, managing editor of Green Chip Stocks, singled out a few stocks he believes &ldquo;are going to continue to see a flood of capital coming in&hellip;. much of which was previously flooding into Canada.&rdquo;</p> <p>&ldquo;The other big news was that <strong>Tilray</strong> filed for an IPO on the NASDAQ,&rdquo; Borchardt said. &ldquo;The company reported solid financial numbers, and that will make this a sought-after offering among cannabis investors. Tilray will be a &lsquo;controlled company&rsquo; since Privateer Holdings will have the majority voting power.&quot;</p> <p>In addition, <strong>High Times</strong>&nbsp;announced its crowdfunding campaign and RegA+ IPO. Investors are now able to purchase shares of the 44-year-old media and entertainment company before its planned Nasdaq stock market listing later this year. This comes after the company announced that it is adding former President of Mexico, Vicente Fox Quesada, to its board.</p> <p><em>Related Link: <a href="https://www.benzinga.com/news/18/02/11188995/former-mexican-president-vicente-fox-talks-nafta-trump-and-regulated-marijuana-t">Former Mexican President Vicente Fox Talks NAFTA, Trump And Regulated Marijuana Trade</a></em></p> <p>&ldquo;The company is only weeks away from publicly listing on the Nasdaq, just weeks after organizing America&#39;s first state-sanctioned recreational cannabis event in Sacramento,&rdquo; Fox told Benzinga. &ldquo;This is an enormous opportunity for the general populous to buy into the growing green rush, and they&#39;re just getting started.&rdquo;</p> <p>See details of the IPO below:</p> <p><img alt="" src="https://cdn2.benzinga.com/files/u82070/most-trusted-media-brand-1.jpg" style="height:329px; width:600px" /></p> <p><em>Source: High Times.</em></p> <p>Despite the news, the <strong>United States Marijuana Index, </strong>which tracks 17 of the largest marijuana stocks in the U.S., lost 3.7 percent this week, while the <strong>North American Marijuana Index</strong>, which also includes Canadian stocks, tumbled less than 1 percent.</p> <p>Over the last five trading days, the <strong>Horizons Marijuana Life Sciences Index ETF</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/hmlsf#OTC">HMLSF</a>) (TSE:HMMJ) gained 7.3 percent, while the <strong>ETFMG Alternative Harvest ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mj#NYSE">MJ</a>) rose almost 4 percent &ndash; and started trading ex-dividend. The <strong>SPDR S&amp;P 500 ETF Trust </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spy#NYSE">SPY</a>) was down 0.7 percent.</p> <h3><strong>Stock Moves</strong></h3> <p>Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days:</p> <ul> <li><strong>22nd Century Group Inc </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NYSE">XXII</a>): up 10.3 percent</li> <li><strong>Aphria Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/aphqf#OTC">APHQF</a>): up 8.2 percent</li> <li><strong>Aurora Cannabis Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/acbff#OTC">ACBFF</a>): up 10.45 percent</li> <li><strong>Cannabis Sativa Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cbds#OTC">CBDS</a>): up 1 percent</li> <li><strong>CannTrust Holdings Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnttf#OTC">CNTTF</a>): up 7.6 percent</li> <li><strong>Canopy Growth Corp </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NYSE">CGC</a>): up 10.2 percent</li> <li><strong>Cronos Group Inc. </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cron#NASDAQ">CRON</a>): up 2.85 percent</li> <li><strong>GW Pharmaceuticals PLC- ADR </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwph#NASDAQ">GWPH</a>): up 3.1 percent</li> <li><strong>Hiku Brands Company Ltd</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/djacf#OTC">DJACF</a>): up 19.4 percent</li> <li><strong>India Globalization Capital, Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/igc#NYSE">IGC</a>): down 1.6 percent</li> <li><strong>iAnthus Capital Holdings Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ithuf#OTC">ITHUF</a>): up 13.15 percent</li> <li><strong>MassRoots Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/msrt#OTC">MSRT</a>): up 0.1 percent</li> <li><strong>MedReleaf Corp</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/medff#OTC">MEDFF</a>): up 18 percent</li> <li><strong>Scotts Miracle-Gro Co </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smg#NYSE">SMG</a>): down 5 percent</li> <li><strong>THC Biomed Intl Ltd </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/thcbf#OTC">THCBF</a>): up 11.8 percent</li> <li><strong>Zynerba Pharmaceuticals Inc </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyne#NASDAQ">ZYNE</a>): down 2.7 percent</li> </ul> <h3><strong>In Other News</strong></h3> <p>A consortium of cannabis-related media professionals are conducting a <strong>Cannabis Media Survey.</strong> You can answer following <a href="http://www.surveymonkey.com/r/CannabisMediaSurvey1">this link</a>.</p> <p><strong>Cronos Group</strong> announced its subsidiary Cronos Australia was granted a medicinal cannabis Manufacture License by the Australian Office of Drug Control. This license allows the company to manufacture cannabinoid-based products in Australia, extracting, refining, concentrating and transforming the cannabis plant.</p> <p><strong>Tidal Royalty Corporation</strong><strong>,</strong> a provider of ...</p><p><a href=http://www.benzinga.com/general/biotech/18/06/11923319/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee alt=Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week>Full story available on Benzinga.com</a></p> ACBFF APHQF BDS Analytics Biotech BrewBudz Canada Canada Cannabis Canada Marijuana Cannabiniers Cannabis Cannabis ETF cannabis news Cannabis Stock Index cannabis stocks Canndescent CBDS CGC Civilized CNTTF COWN CRON Cy Scott Debra Borchardt Derek Riedle DJACF Green Market Report GreenWave GWPH H Headset High Times HMLSF HSTRF HYYDF IGC IIPR invest in marijuana ITHUF Jeff Harris Jeff Siegel Larisa Bolivar Long Ideas marijuana Marijuana ETF Marijuana Index Marijuana Money marijuana news marijuana stocks Mazakali MEDFF Michigan cannabis Michigan Marijuana MJ MJNA MSRT New Frontier Data News North American Marijuana Index ONE Cannabis Paul Rosen Postmedia Pot Stocks PRMCF Ricardo Baca Sector ETFs SMG SPY Stuart Titus Sumit Mehta THCBF The Fresh Toast The+Source TheGrowthOp Tidal Royalty Tilray TRTC United States Marijuana Index Vicente Fox Vivien Azer XXII ZYNE Emerging Markets Specialty ETFs Health Care Emerging Market ETFs Politics M&A IPOs Top Stories Markets Movers Trading Ideas Interview ETFs General IGC US45408X1000 SPY US78462F1030 COWN US2236221014 SMG US8101861065 H US4485791028 CGC MJNA US58463A1051 TRTC ITHUF XXII CNTTF HSTRF GWPH CBDS MSRT ZYNE THCBF ACBFF APHQF MJ PRMCF IIPR DJACF HYYDF MEDFF HMLSF CRON Long Ideas Sector ETFs News Biotech Specialty ETFs Emerging Markets Health Care Emerging Market ETFs Politics M&A IPOs Top Stories Markets Movers Trading Ideas Interview ETFs General Benzinga Fri, 22 Jun 2018 20:20:50 +0000 Javier Hasse 11923319 at www.benzinga.com Analysts React To Red Hat's Q1 Earnings, Downbeat Forecast http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11922338/analysts-react-to-red-hats-q1-earnings-downbeat-forecas <p><strong>Red Hat Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rht#NYSE">RHT</a>) stock tanked more than 12&nbsp;percent Friday after <a href="https://www.benzinga.com/pressreleases/18/06/b11917521/red-hat-reports-first-quarter-results-for-fiscal-year-2019">the company&rsquo;s first-quarter earnings report</a> failed to wow the market. Red Hat also announced a $1 billion buyback.</p> <p>A number of analysts have weighed in on Red Hat stock following the report. Here&rsquo;s a sampling of what they had to say.</p> <h3>Billings Slowdown</h3> <p>Morgan Stanley analyst Keith Weiss said Red Hat failed to follow its winning recipe of sustaining billings while improving margins.</p> <p>&ldquo;Red Hat began FY19 on an underwhelming note, with Q1 billings slowing to 9% cc after growing 20% in FY18 and missing consensus by ~2%,&rdquo; Weiss wrote in a note.</p> <p>Raymond James said slowing middleware growth unfavorable forex environment and lower contract duration weighed on Red Hat&rsquo;s Q1.</p> <p>&ldquo;Billings growth slowed meaningfully to 9%CC last quarter, hurt by shorter duration and potentially just less positive ordering trends,&rdquo; the ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11922338/analysts-react-to-red-hats-q1-earnings-downbeat-forecas alt=Analysts React To Red Hat&#039;s Q1 Earnings, Downbeat Forecast>Full story available on Benzinga.com</a></p> Analyst Color Brad Zelnick Credit Suisse Earnings Ittai Kidron Jason Ader Keith Weiss Morgan Stanley News Oppenheimer RHT William Blair Price Target Top Stories Analyst Ratings Trading Ideas RHT US7565771026 News Analyst Color Earnings Price Target Top Stories Analyst Ratings Trading Ideas Benzinga Fri, 22 Jun 2018 17:21:50 +0000 Wayne Duggan 11922338 at www.benzinga.com Wedbush Sees Strong Trends Backing Discount Retail http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11921791/wedbush-sees-strong-trends-backing-discount-retail <p>Wedbush initiated coverage on three retailers, highlighting strong macro trends and business models that made it difficult for e-commerce rivals to replicate.</p> <h3>The Ratings</h3> <p>Wedbush analyst Jen Redding initiated coverage of <strong>Burlington Stores Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/burl#NYSE">BURL</a>) at Outperform with a $175 price target.</p> <p>Redding came out with Neutral ratings on both <strong>Ross Stores, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rost#NASDAQ">ROST</a>) and <strong>TJX Companies Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tjx#NYSE">TJX</a>) with $90 and $100 price targets, respectively.</p> <h3>The Theses</h3> <p>There is &ldquo;no end in sight in the run-up for off-price goods,&rdquo; according to Redding, making the companies attractive growth stories.</p> <p>There are three other key factors, in Redding&rsquo;s view, supporting the discount retail ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11921791/wedbush-sees-strong-trends-backing-discount-retail alt=Wedbush Sees Strong Trends Backing Discount Retail>Full story available on Benzinga.com</a></p> Analyst Color BURL Jen Redding ROST TJX Wedbush Price Target Initiation Top Stories Analyst Ratings Trading Ideas ROST US7782961038 TJX US8725401090 BURL Analyst Color Price Target Initiation Top Stories Analyst Ratings Trading Ideas Benzinga Fri, 22 Jun 2018 16:55:57 +0000 Ezra Schwarzbaum 11921791 at www.benzinga.com Russell 1000 ETFs To Increase In Health Care, Tech Exposure http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11918865/russell-1000-etfs-to-increase-in-health-care-tech-expos <p>Index provider FTSE Russell finalizes its annual index reconstitution today, making for brisk trading activity as well as some changes for some well-known exchange traded funds.</p> <p>Each year on the final Friday of June, &ldquo;stocks are added or deleted to the Russell 1000 large cap and Russell 2000 small cap, prompting fund managers to adjust their portfolios to reflect new weightings,&rdquo; <a href="https://www.reuters.com/article/us-usa-stocks-russell/tech-healthcare-to-get-bumped-up-in-russell-index-remake-idUSKBN1JH32B">reports Reuters</a>.</p> <h3>What Happened</h3> <p>The <strong>iShares Russell 2000 ETF</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iwm#NYSE">IWM</a>), the largest small-cap ETF, tracks the aforementioned Russell 2000 Index. As of June 20, the technology and health care sectors combined for nearly <a href="https://www.ishares.com/us/products/239710/?referrer=tickerSearch">35 percent of IWM&#39;s weight</a>, representing two of the ETF&#39;s top three sector allocations.</p> <p>That could change because small-cap health care and technology stocks have ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/18/06/11918865/russell-1000-etfs-to-increase-in-health-care-tech-expos alt=Russell 1000 ETFs To Increase In Health Care, Tech Exposure>Full story available on Benzinga.com</a></p> Analyst Color FTSE Russell IWB IWD IWF IWM JJ Kinahan Long Ideas News Broad U.S. Equity ETFs Top Stories Markets Trading Ideas Interview ETFs IWB US4642876225 IWD US4642875987 IWF US4642876142 IWM US4642876555 Long Ideas News Analyst Color Broad U.S. Equity ETFs Top Stories Markets Trading Ideas Interview ETFs Benzinga Fri, 22 Jun 2018 16:41:59 +0000 ETF Professor 11918865 at www.benzinga.com OPEC Announces Increase In Output, Declines To Provide Firm Number http://www.benzinga.com/news/18/06/11921497/opec-announces-increase-in-output-declines-to-provide-firm-number <p>Oil investors are cheering and oil prices are on the rise Friday following <a href="https://www.cnbc.com/2018/06/22/opec-ministers-strike-deal-on-oil-production-levels.html">a production cap&nbsp;announcement</a> from OPEC.</p> <h3>What Happened</h3> <p>At its meeting in Vienna Friday, OPEC announced that it will begin to raise its output but did not provide details about the extent of the&nbsp;hike. OPEC only said that it will no longer be cutting output beyond the 1.2-million-barrel-per-day cut it announced in November 2016. OPEC said it will not exceed 100-percent compliance with those previous decreases after cuts peaked at 152 percent &mdash; or 1.8 million bpd &mdash; in ...</p><p><a href=http://www.benzinga.com/news/18/06/11921497/opec-announces-increase-in-output-declines-to-provide-firm-number alt=OPEC Announces Increase In Output, Declines To Provide Firm Number>Full story available on Benzinga.com</a></p> CNBC News OPEC USO Wall Street Journal Specialty ETFs Commodities Events Top Stories Markets Media ETFs USO US91232N1081 News Specialty ETFs Commodities Events Top Stories Markets Media ETFs Benzinga Fri, 22 Jun 2018 16:00:08 +0000 Wayne Duggan 11921497 at www.benzinga.com